Related Experiment Video
Updated: Feb 18, 2026
11:47
Treating SCA1 Mice with Water-Soluble Compounds to Non-Specifically Boost Mitochondrial Function
Published on: January 22, 2017
11.2K
Anticonvulsant Medications in Mitochondrial Disease
Divakar S Mithal1, Jonathan E Kurz1
1Division of Neurology, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL; and Departments of Pediatrics and Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL.
Pediatric Neurology Briefs
|November 30, 2017
Summary
This study reviews how anticonvulsant drugs affect mitochondria in epilepsy. Levetiracetam
Area of Science:
- Biochemistry
- Neuroscience
- Pharmacology
Background:
- Mitochondrial dysfunction is implicated in various neurological disorders, including epilepsy.
- Anticonvulsant drugs are primary treatments for epilepsy, but their effects on cellular energy production are not fully understood.
Purpose of the Study:
- To investigate the impact of anticonvulsant medications on mitochondrial function.
- To specifically examine the effects of levetiracetam on mitochondrial membrane potential in the context of epilepsy.
Main Methods:
- A comprehensive literature search was conducted.
- Studies focused on the intersection of epilepsy, mitochondrial disease, and anticonvulsant drug mechanisms.
- Specific attention was given to levetiracetam and its influence on mitochondrial membrane potential.
Main Results:
- The literature search identified a complex relationship between anticonvulsant drugs and mitochondrial function.
- Levetiracetam's effects on mitochondrial membrane potential were found to be context-dependent, varying with specific mitochondrial diseases.
Conclusions:
- Understanding the mitochondrial effects of anticonvulsants like levetiracetam is crucial for optimizing epilepsy treatment.
- Further research is needed to elucidate the precise mechanisms and therapeutic implications of these drug-mitochondria interactions.
Related Concept Videos
01:14Antiepileptic Drugs: Glutamate Antagonists
1.0K
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
1.0K
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
957
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
957
01:08Antiepileptic Drugs: Sodium Channel Blockers
1.8K
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
1.8K
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
1.4K
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.4K
01:46Electron Transport Chain: Complex I and II
19.1K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
19.1K
01:24Mania and Antimanic Drugs: Overview
666
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
666